| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 21, 2026 | ±2.8% | -3.0% | under-priced |
| October 21, 2025 | ±2.7% | -0.5% | over-priced |
| July 22, 2025 | ±2.0% | -8.2% | under-priced |
| April 22, 2025 | ±3.2% | +13.8% | under-priced |
| July 22, 2024 | ±3.4% | +3.6% | under-priced |
| April 22, 2024 | ±4.6% | +1.3% | over-priced |
| October 23, 2023 | ±4.3% | +1.5% | over-priced |
| July 25, 2023 | ±4.2% | +0.7% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.42 | $1.6B | $173M |
| Q4 FY2025 | $1.43 | $1.6B | $176M |
| Q3 FY2025 | $1.29 | $1.5B | $162M |
| Q2 FY2025 | $1.53 | $1.5B | $193M |
Equifax, Incorporated (EFX) reports in 106 days, with the next report estimated for September 27, 2026. Across the last 8 reports, options priced an average ±3.4% earnings move while the stock actually moved 4.1% on average — the market has been roughly fair on EFX's earnings risk. Fundamentals into the print: EPS up 34.0% year-over-year, revenue up 14.3%. QuantLogix's live 5-factor engine currently reads EFX as a neutral at 49/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →